Iq Eq Fund Management (Ireland) LTD Veracyte, Inc. Transaction History
Iq Eq Fund Management (Ireland) LTD
- $831 Million
- Q4 2024
A detailed history of Iq Eq Fund Management (Ireland) LTD transactions in Veracyte, Inc. stock. As of the latest transaction made, Iq Eq Fund Management (Ireland) LTD holds 18,156 shares of VCYT stock, worth $598,421. This represents 0.09% of its overall portfolio holdings.
Number of Shares
18,156
Previous 9,541
90.29%
Holding current value
$598,421
Previous $324,000
121.6%
% of portfolio
0.09%
Previous 0.03%
Shares
2 transactions
Others Institutions Holding VCYT
# of Institutions
338Shares Held
80.4MCall Options Held
212KPut Options Held
18.5K-
Vanguard Group Inc Valley Forge, PA8.21MShares$271 Million0.01% of portfolio
-
Black Rock Inc. New York, NY7.79MShares$257 Million0.0% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI6.6MShares$218 Million0.42% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl4.2MShares$139 Million1.46% of portfolio
-
Wellington Management Group LLP Boston, MA4.08MShares$135 Million0.03% of portfolio
About VERACYTE, INC.
- Ticker VCYT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,575,904
- Market Cap $2.36B
- Description
- Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...